Canbridge Pharmaceuticals Relocates Hong Kong Office to Dah Sing Financial Centre

Reuters
07/11
Canbridge Pharmaceuticals Relocates <a href="https://laohu8.com/S/HKRHF">Hong Kong</a> Office to <a href="https://laohu8.com/S/DAHSF">Dah Sing</a> Financial Centre

CANbridge Pharmaceuticals Inc. has announced a change in its principal place of business in Hong Kong. Effective July 11, 2025, the company will relocate to the 40th Floor of Dah Sing Financial Centre, located at No. 248 Queen's Road East, Wanchai, Hong Kong. The company's website will remain unchanged. The Board of Directors includes Dr. James Qun Xue as executive Director, among others.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Canbridge Pharmaceuticals Inc. published the original content used to generate this news brief on July 11, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10